Candriam S.C.A. Invests $4.93 Million in Omega Healthcare Investors, Inc. $OHI

Key Points

• Candriam S.C.A. has acquired a $4.93 million stake in Omega Healthcare Investors, purchasing 129,513 shares in the first quarter.
• Omega Healthcare Investors announced a quarterly dividend of $0.67 per share, resulting in an annualized dividend yield of 6.4%.
• Analysts have updated their price targets for Omega Healthcare Investors, with the average target now at $42.00 and a consensus rating of "Hold."

Candriam S.C.A. acquired a new stake in shares of Omega Healthcare Investors, Inc. (NYSE:OHI - Free Report) in the first quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm acquired 129,513 shares of the real estate investment trust's stock, valued at approximately $4,932,000.

Several other hedge funds and other institutional investors also recently bought and sold shares of OHI. Vanguard Group Inc. raised its holdings in Omega Healthcare Investors by 3.9% in the first quarter. Vanguard Group Inc. now owns 39,554,886 shares of the real estate investment trust's stock valued at $1,506,250,000 after acquiring an additional 1,492,904 shares in the last quarter. Invesco Ltd. lifted its position in shares of Omega Healthcare Investors by 122.3% during the first quarter. Invesco Ltd. now owns 2,416,560 shares of the real estate investment trust's stock worth $92,023,000 after purchasing an additional 1,329,324 shares during the last quarter. Nuveen LLC bought a new position in shares of Omega Healthcare Investors during the first quarter worth about $42,513,000. Northern Trust Corp grew its stake in Omega Healthcare Investors by 49.4% in the fourth quarter. Northern Trust Corp now owns 3,274,793 shares of the real estate investment trust's stock worth $123,951,000 after purchasing an additional 1,083,326 shares in the last quarter. Finally, Allspring Global Investments Holdings LLC increased its holdings in Omega Healthcare Investors by 556.1% in the first quarter. Allspring Global Investments Holdings LLC now owns 1,028,187 shares of the real estate investment trust's stock valued at $39,143,000 after buying an additional 871,472 shares during the last quarter. 65.25% of the stock is currently owned by hedge funds and other institutional investors.

Insider Transactions at Omega Healthcare Investors

In other Omega Healthcare Investors news, Director Lisa Egbuonu-Davis sold 2,500 shares of the firm's stock in a transaction dated Friday, August 8th. The shares were sold at an average price of $40.16, for a total transaction of $100,400.00. Following the transaction, the director owned 18,654 shares of the company's stock, valued at approximately $749,144.64. This trade represents a 11.82% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. 1.50% of the stock is owned by corporate insiders.

Omega Healthcare Investors Stock Performance

Shares of NYSE OHI traded down $0.73 during midday trading on Thursday, hitting $41.90. 571,395 shares of the company's stock were exchanged, compared to its average volume of 2,382,009. Omega Healthcare Investors, Inc. has a twelve month low of $35.04 and a twelve month high of $44.42. The firm has a market cap of $12.36 billion, a P/E ratio of 25.86, a PEG ratio of 2.23 and a beta of 0.66. The stock's 50 day moving average price is $38.84 and its 200-day moving average price is $37.70. The company has a debt-to-equity ratio of 0.96, a current ratio of 7.10 and a quick ratio of 7.10.

Omega Healthcare Investors (NYSE:OHI - Get Free Report) last announced its earnings results on Thursday, July 31st. The real estate investment trust reported $0.77 earnings per share for the quarter, beating the consensus estimate of $0.45 by $0.32. Omega Healthcare Investors had a return on equity of 9.78% and a net margin of 42.23%.The firm had revenue of $235.60 million for the quarter, compared to the consensus estimate of $248.49 million. During the same quarter in the previous year, the business earned $0.71 EPS. The firm's revenue for the quarter was up 11.8% on a year-over-year basis. Omega Healthcare Investors has set its FY 2025 guidance at 3.040-3.070 EPS. Equities research analysts anticipate that Omega Healthcare Investors, Inc. will post 2.86 EPS for the current year.

Omega Healthcare Investors Dividend Announcement

The business also recently disclosed a quarterly dividend, which was paid on Friday, August 15th. Investors of record on Monday, August 4th were issued a $0.67 dividend. The ex-dividend date of this dividend was Monday, August 4th. This represents a $2.68 annualized dividend and a yield of 6.4%. Omega Healthcare Investors's dividend payout ratio is presently 165.43%.

Analysts Set New Price Targets

Several research analysts have recently commented on the company. Royal Bank Of Canada lifted their target price on Omega Healthcare Investors from $39.00 to $41.00 and gave the stock a "sector perform" rating in a research report on Thursday, August 7th. Wells Fargo & Company increased their target price on shares of Omega Healthcare Investors from $41.00 to $44.00 and gave the stock an "overweight" rating in a report on Wednesday. Finally, Scotiabank restated a "sector perform" rating on shares of Omega Healthcare Investors in a research report on Thursday. Four analysts have rated the stock with a Buy rating and five have assigned a Hold rating to the company. According to data from MarketBeat.com, the stock presently has an average rating of "Hold" and a consensus price target of $42.86.

About Omega Healthcare Investors

Omega Healthcare Investors, Inc engages in the provision of financing and capital to the long-term healthcare industry with a particular focus on skilled nursing facilities, assisted living facilities, independent living facilities, rehabilitation and acute care facilities, and medical office buildings.